Objective
To compare the gestational age of neonates in utero exposed to
benzodiazepines (BDZs) with none exposed controls. Secondary objectives
were; birth weight, presence of congenital malformations, APGAR score,
and the need for > 3 months (prolonged) maternal
psychiatric care.